Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma.
Sobell Department, UCL Institute of Neurology, , London, UK.
Benedetta
B
Demartini
Lucia
L
Ricciardi
Alexandra
A
Ward
Mark J
MJ
Edwards
D000634:Aminoquinolines / Q000009:adverse effects*; D018491:Dopamine Agonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015175:Prolactinoma / Q000150:complications* / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*
D000634:Aminoquinolines; D018491:Dopamine Agonists; C046650:quinagolide
ENDOCRINOLOGY; PHARMACOLOGY; PSYCHOLOGY